Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Association between Fetal Cerebral Ventriculomegaly and Platelet Alloimmunisation

View through CrossRef
<b><i>Introduction:</i></b> Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare condition that may lead to intracerebral haemorrhage (ICH) in the fetus or neonate. Platelet alloimmunisation causing FNAIT has been described in association with fetal cerebral ventriculomegaly (VM), presumably due to subclinical ICH. The objective of this study was to assess the association between fetal VM and platelet alloimmunisation. <b><i>Methods:</i></b> This is a case series of pregnancies with fetal VM screened for platelet alloantibodies from 2003 to 2012. Cases of multiple pregnancies, structural anomalies, aneuploidies, or congenital infection were excluded. <b><i>Results:</i></b> Of 45 pregnancies with fetal VM that were screened for platelet alloantibodies, 5 (11%) were positive. There was only one antenatal ICH, with confirmed fetal severe thrombocytopenia before termination of pregnancy. The other cases were treated with intravenous immunoglobulins without prior fetal blood sampling. No other case of neonatal thrombocytopenia was confirmed. <b><i>Conclusions:</i></b> The prevalence of platelet alloimmunisation was high in this series of fetal VM. Prospective large studies are needed to confirm the role of platelet alloimmunisation in fetal VM.
Title: Association between Fetal Cerebral Ventriculomegaly and Platelet Alloimmunisation
Description:
<b><i>Introduction:</i></b> Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare condition that may lead to intracerebral haemorrhage (ICH) in the fetus or neonate.
Platelet alloimmunisation causing FNAIT has been described in association with fetal cerebral ventriculomegaly (VM), presumably due to subclinical ICH.
The objective of this study was to assess the association between fetal VM and platelet alloimmunisation.
<b><i>Methods:</i></b> This is a case series of pregnancies with fetal VM screened for platelet alloantibodies from 2003 to 2012.
Cases of multiple pregnancies, structural anomalies, aneuploidies, or congenital infection were excluded.
<b><i>Results:</i></b> Of 45 pregnancies with fetal VM that were screened for platelet alloantibodies, 5 (11%) were positive.
There was only one antenatal ICH, with confirmed fetal severe thrombocytopenia before termination of pregnancy.
The other cases were treated with intravenous immunoglobulins without prior fetal blood sampling.
No other case of neonatal thrombocytopenia was confirmed.
<b><i>Conclusions:</i></b> The prevalence of platelet alloimmunisation was high in this series of fetal VM.
Prospective large studies are needed to confirm the role of platelet alloimmunisation in fetal VM.

Related Results

Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Abstract Introduction In patients with 70% to 99% diameter carotid artery stenosis cerebral blood flow reserve may be protectiv...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an enviro...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Abstract Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposi...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Plasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect of aspi...
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
AbstractPlasma and platelet factor Va represent different substrates for activated protein C (APC). In this study, we have measured platelet-dependent APC resistance and the effect...
Platelet Antagonists
Platelet Antagonists
Platelet antagonists play an important role in both primary and secondary prevention of atherothrombotic events. Despite their proven benefit, individual response (and protection) ...

Back to Top